The Europe region held the largest market share in the global Medical and Research Grade Collagen market. The demand for medical and research grade collagen is projected to boost in these countries over the forecast period, mainly due to the rising prevalence of cardiovascular diseases among the people. The higher health expenditure of the people due to high income further leads to an increasing demand for medical and research grade collagen in the Europe region. The European market is characterized by the presence of players such as DSM, Collagen Solutions Plc, Croda International Plc., Advanced Biomatrix Inc, Collagen Matrix, Inc., Cologenesis Healthcare Pvt Ltd., Innocoll Holdings Plc., Integra LifeSciences Corporation, Nitta Gelatin, Na Inc., and Rousselot, among others.
Collagen is the major fibrous protein in the extra-cellular matrix and connective tissues. Approximately, more than 80% of the skin is composed of collagen. Collagen is also the main component of the ligaments and tendons. Collagen can be used as a biological skin substitute. Biological properties such as low antigenicity, no toxicity, and minimal biodegradation make it a favorable biomaterial in applications such as reconstructive surgeries. Collagen scaffolds have been widely used in the field of tissue engineering. The rise in the aging population across the world, and growing incidences of age-related diseases such as osteoporosis, arteriosclerosis, cancer, etc. is expected to drive the market for bio-materials such as collagen used in reconstructive surgeries.
Collagen is a widely recognized biomaterial used in the pharmaceutical and health care industry. Collagen can be molded into artificial implants, and scaffolds for regeneration of tissues owing to their excellent biocompatibility. The use of collagen as excipients for various forms of drugs, and as vector systems for the controlled release of active substances in the pharmaceutical industry is expected to boost the sales of pharmaceutical and medical grade collagen. It is also used to enhance the elasticity and suppleness of the skin by repairing damage caused to skin by aging and exposure to sunlight and UV radiation. The primary medical application of collagen is catgut suture, which is derived from the intestinal collagen of bovines. Catgut sutures are used to promote wound healing. Demand for hydrolyzed collagen is anticipated to grow as it is widely used in surgical procedures such as bone grafting, tissue engineering, and dental surgeries. Moreover, high demand for good-quality native collagen used as an ingredient in formulating creams and ointments as an anti-aging agent and skin rejuvenator is expected to drive the market over the forecast period.
Based on the source, the global medical and research grade collagen market has been segmented into bovine, porcine, poultry, marine, and others. Under the source segment, the bovine market led the global medical and research grade collagen market. Moreover, the porcine segment is anticipated to register the fastest CAGR over the projected period. Collagen is abundantly available protein in mammal tissue, and it has been used in medical applications for centuries. Bovine is basically obtained from the bone and skin of the cow. The use of this type of collagen is impacted by the cow’s development stage. This collagen delivers 18 amino acids, which include eight essential amino acids. It is a viable source of proline and glycine. Bovine collagen is used to produce medical devices, and this collagen is derived from purified collagen extracts obtained from the bovine dermis. Many of the companies get the bovine raw material for medical applications mainly from veterinary controlled herds. This further boost the overall medical and research grade collagen market globally.
The global medical and research grade collagen market by-products have been segmented into gelatin, hydrolyzed collagen, native collagen, and others. The gelatin segment accounted for the largest share in the global medical and research grade collagen market. Gelatin is the heat-denatured type of collagen protein which contains collagen, which is used to make cartilage and bone. It is widely used as a common ingredient in several products such as food, cosmetics, medicine, and vaccines. During the past few years, research institutes were involved in bringing major innovations in regenerative medicine, cell research, and transplantation. The advanced techniques of combining gelatin with cells are making new treatment methods more effective. Gelatin is utilized for food, pharmaceutical, and photosensitized materials owing to its film-forming, water binding, and adhesive properties. These factors are known to propel the growth of the Medical and Research Grade Collagen market over the forecast period.
The regional trends and factors influencing the Medical and Research Grade Collagen Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Medical and Research Grade Collagen Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 495.4 Million |
| Market Size by 2027 | US$ 884.2 Million |
| Global CAGR (2018 - 2027) | 6.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Source
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Medical and Research Grade Collagen Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Medical and Research Grade Collagen Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Strategy and business planning were observed as the most adopted strategies in global medical and research grade collagen market. Few of the recent developments in the global medical and research grade collagen market are listed below:
2019:Collagen Solutions plc has announced that it has entered into a new license and distribution agreement for ChondroMimetic with an Indonesian partner, PT Rajawali Mutiara Sejahtera ("Rajawali Medika"). Rajawali Medika has collaborated with Collagen Solutions Plc to obtain regulatory approval and to launch ChondroMimetic in Indonesia with the potential to expand to several other South East.
2018:Rousselot is has announced Firmalis as its official, exclusive Peptan collagen solution distributor in France. Firmalis specializes in the distribution of flavors and ingredients for the food and nutrition industry, offering a wide range of products and services and backed by 50 years of experience.
The List of Companies